CO23 Real-World Treatment Patterns and Survival with First-Line (1L) Pembrolizumab + Platinum + Taxane Therapy for Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the United States

Autor: Black, C. 1, Hanna, G.J. 2, Wang, L. 1, Ramakrishnan, K. 1, Hair, G. 1, Zheng, D. 1, Goto, D. 1
Zdroj: In Value in Health June 2023 26(6) Supplement:S18-S18
Databáze: ScienceDirect
Externí odkaz: